Navigation Links
PLC Systems Reports Second Quarter 2010 Results
Date:8/16/2010

FRANKLIN, Mass., Aug. 16 /PRNewswire-FirstCall/ -- PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today reported financial results for the three- and six month periods ended June 30, 2010.

Second quarter 2010 total revenues were $1,019,000, a decrease from $1,220,000 reported in the second quarter of 2009, and a decrease of $43,000 from $1,062,000 reported in the first quarter of 2010. The net loss for the second quarter of 2010 was $199,000, or $0.01 per basic and diluted share, compared to a net loss of $307,000, or $0.01 per basic and diluted share, in the second quarter of 2009.  

Mark R. Tauscher, president and chief executive officer of PLC Systems Inc., stated, "We were very pleased in the past quarter to share the positive scientific evidence that RenalGuard® is safe and effective at significantly reducing rates of Contrast-Induced Nephropathy (CIN) in at-risk patients with our current and potential distributors in Europe during EuroPCR. The number of single-use sets for RenalGuard procedures shipped during the second quarter this year reached the highest level yet, 589 units, which is 55% higher than the second quarter last year and 100% higher in the first half of 2010 than in the prior year period. While the speed of adoption and use of RenalGuard is never as fast as we would wish, we believe these numbers demonstrate that we are making progress in the European Union countries where it is available.  The two investigator-sponsored clinical trials of our RenalGuard System™ underway in Italy, MYTHOS and REMEDIAL II, continue to enroll more patients, and we anticipate that they will be completed and report final results on top of the consistently positive interim results we have seen, later this year.  We believe this data, in addition to our enhan
'/>"/>

SOURCE PLC Systems Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
2. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
3. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
4. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
5. Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
6. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
7. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
8. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
9. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
10. PLC Systems Reports Fourth Quarter 2007 Results
11. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... -- Edelberg & Associates (EA) and ScribeAmerica today are ... coding software platform designed to engage and successfully ... at the point of care.  In a significant ... successfully built, deployed and tested a new proprietary ... medical coder that can radically improve natural latencies ...
(Date:3/30/2015)... March 30, 2015 DURECT Corporation (Nasdaq: ... initiated a multi-dose Phase 1 clinical trial of ... in DURECT,s Epigenomic Regulator Program.  DUR-928 is an ... have broad applicability in metabolic diseases such as ... (NASH).  It may also play an important role ...
(Date:3/30/2015)... --  GlassesUSA , the online retailer specializing in prescription ... financing led by Viola Private Equity , a member ... business growth and accelerate their expansion as a leading player ... and B2B. GlassesUSA was founded in 2009 by ... and CTO Roy Yamner . Leveraging their vast experience ...
Breaking Medicine Technology:Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 2Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3
... complained for years about the mental fog known ... University, researchers have discovered,that injections of N-acetyl cysteine ... breast cancer chemotherapy drugs sometimes induce., In ... issue of the,journal Metabolic Brain Disease, rats were ...
... 4 Cytopia Limited (ASX:,CYT) today announced that ... of CYT997, the company,s novel vascular-disrupting anticancer agent,in ... known as glioblastoma,multiforme (GBM)., The GBM clinical ... in highly,vascular, solid tumor indications for the company ...
Cached Medicine Technology:Study Suggests a Possible Way to Offset Chemobrain Memory Loss 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3
(Date:3/30/2015)... 30, 2015 FMC Corporation’s Health ... for all current Epax® Ultra and Core concentrates ... Norway. The certification ensures the manufacturing process and ... Islamic religious regulations for Halal. , The ... efforts to further advance its customer service to ...
(Date:3/30/2015)... Angeles, CA (PRWEB) March 30, 2015 ... traditional blue polo for yellow to inspire courage in ... suffers from Severe Combined Immunodeficiency (SCID). SCID causes affected ... bone marrow transplant is needed to allow the development ... second transplant last Friday, created a video with his ...
(Date:3/30/2015)... 2015 GenSight ®, provider of ... as a leader in The Forrester Wave™: Strategic Planning ... , The independent report positions GenSight as a leader ... out of 5) for the analytics, corporate strategy, assessment, ... to GenSight’s position in the Leaders category. , According ...
(Date:3/30/2015)... V/NO (Virtually No Alcohol) Wines have a sleek single-serve ... for reuse. Consumers simply twist the cup, turn it upward ... and basically anyone can now enjoy a non-alcoholic wine ... or pair with meals at work, home, or wherever the ... and that means Napa Wine grapes undergo the traditional wine ...
(Date:3/30/2015)... 30, 2015 The “Orthopedic ... EHR, Orthopedic PACS) By Applications (Orthopedic Surgery, ... Mode of Delivery] – Global Forecast to ... restraints and opportunities in North America, Europe, ... (RoW). , Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=94720371 ...
Breaking Medicine News(10 mins):Health News:FMC Health and Nutrition Announces Halal Certification for Epax® Brand Omega-3 Ingredients 2Health News:24Hr HomeCare Staff Hosts #WearYellowForSeth Campaign for Five-Year-Old Boy with Severe Combined Immunodeficiency 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 3Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 2Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 3Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 4
... YORK, Dec. 30 Delcath Systems, Inc. (Nasdaq: ... host its quarterly update conference call at 4:30 PM ... President and Chief Executive Officer of Delcath Systems, will ... progress of patient enrollment and the advancement of clinical ...
... David B. Snow Jr., chairman and chief executive officer, Medco ... to address the Goldman Sachs Healthcare CEOs Unscripted: A View ... 7, 2009.The Medco presentation will begin at 11:15 a.m. EST ... to attend. Additionally, Snow will participate on a CEO ...
... exercise might help offset the effect, study suggests , , ... what appears to be a major mechanism contributing to ... that is amenable to change: rising blood glucose levels, ... Researchers reporting in the December issue of Annals ...
... the following Webcast: , , What: Neogen Corporation ... 2009 @ 11:00 EST, Where: http://www.videonewswire.com/event.asp?id=53900 , ... to the web at the address, ... Neogen Corporation, +1-800-234-5333., , If you are unable to ...
... December 30 , - Stubbing ... Your Child,GBP15,500 on Their 18th Birthday , ... ) is encouraging all parents who decide,to give up smoking ... they will save towards their children,s futures. , ...
... Committee for Quality,Assurance and the American Diabetes Association ... Barnett, M.D., Mirela Sturzu,M.D., Rudolf Teschan, M.D., and ... Recognition Program for providing quality care to,patients with ... and Zaki practice at the Aurora Health Center, ...
Cached Medicine News:Health News:Delcath Systems to Host Quarterly Update Conference Call 2Health News:Delcath Systems to Host Quarterly Update Conference Call 3Health News:Medco CEO to Present at the 2009 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conference 2Health News:Rising Blood Sugar May Harm the Aging Brain 2Health News:Rising Blood Sugar May Harm the Aging Brain 3Health News:Urging New Year Quitters to Invest in Their Family's Futures 2Health News:Aurora Physicians Receive National Recognition for Quality Diabetes Care 2
... single use suturing device has application ... of interrupted or running stitches in ... use suturing device is available in ... with the choice of 4 suture ...
... of a 42" long suture inserted into a ... one end and scored on the other. The ... to a ST-3 needle. The opposite end of ... of the plastic tube. The scored end acts ...
This ENDOLOOP suture has a suture type - 0 MONOCRYL and a 1.5 inch diameter....
... inserted into a plastic tube. The plastic tube is ... The suture protrudes from the narrow end and is ... becomes secure after the device is activated. The opposite ... end of the plastic tube. The scored end acts ...
Medicine Products: